OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation
Shuai Yan, Lu Chen, Hao Zhuang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3046-3060
Open Access | Times Cited: 6
Shuai Yan, Lu Chen, Hao Zhuang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3046-3060
Open Access | Times Cited: 6
Showing 6 citing articles:
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Organoids and spheroids: advanced in vitro models for liver cancer research
Mirella Pastore, A. Giachi, Elena Spínola-Lasso, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Mirella Pastore, A. Giachi, Elena Spínola-Lasso, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies
Xue Jiang, Xiaoying Ge, Yueying Huang, et al.
Cancer Letters (2025), pp. 217472-217472
Closed Access
Xue Jiang, Xiaoying Ge, Yueying Huang, et al.
Cancer Letters (2025), pp. 217472-217472
Closed Access
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway
Yuhong Tang, Songsong Fan, Rui Peng, et al.
Translational Oncology (2025) Vol. 53, pp. 102294-102294
Closed Access
Yuhong Tang, Songsong Fan, Rui Peng, et al.
Translational Oncology (2025) Vol. 53, pp. 102294-102294
Closed Access
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research
Carlo Airola, Maria Pallozzi, Eleonora Cesari, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1726-1726
Open Access | Times Cited: 2
Carlo Airola, Maria Pallozzi, Eleonora Cesari, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1726-1726
Open Access | Times Cited: 2
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
Karoline B. Waitman, Holli‐Joi Martin, Jorge Antonio Elias Godoy Carlos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Karoline B. Waitman, Holli‐Joi Martin, Jorge Antonio Elias Godoy Carlos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
